Eugia US LLC recalls
Eugia US LLC is named on 13 recalls in Recall Relay's records since November 2023, from FDA (15 recalled products: FDA lists each product as its own recall); the most recent was May 18, 2026.
All 15 recalled products, newest first.
-
Class IIIofficial
Eugia US LLC recalls Lidocaine HCl InjectionLabeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
-
Class IIofficial
Eugia US LLC recalls Gentamicin InjectionFailed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
-
Class IIofficial
Eugia US LLC recalls Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL)Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
-
Class IIofficial
Eugia US LLC recalls Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL)Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
-
Class IIofficial
Eugia US LLC recalls Testosterone Cypionate InjectioncGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
-
Class IIofficial
Eugia US LLC recalls Progesterone Injection USPPresence of Particulate Matter: A market complaint was received of a glass piece in the vial.
-
Class IIofficial
Eugia US LLC recalls medroxyPROGESTERone Acetate Injectable SuspensionCGMP Deviations
-
Class IIofficial
Eugia US LLC recalls Progesterone InjectionPresence of Particulate Matter: Complaint received of a glass particle in the vial.
-
Class IIofficial
Eugia US LLC recalls Dexamethasone Sodium Phosphate injection USPFailed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
-
Class IIIofficial
Eugia US LLC recalls Eptifibatide injection 20mg/10mL (2mg/mL)Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
-
Class IIofficial
Eugia US LLC recalls Tobramycin for InjectionFailed Stability Specification: Water determination was found not complying with specification.
-
Class IIofficial
Eugia US LLC recalls Methylprednisolone acetate Injectable SuspensionFailed Dissolution Specifications
-
Class IIofficial
Eugia US LLC recalls Nicardipine Hydrochloride Injection (2.5mg/mL)Failed Impurities/Degradation Specifications: Out of specification for organic impurities
-
Class IIofficial
Eugia US LLC recalls Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impurities
-
Class Iofficial
Eugia US LLC recalls Methocarbamol InjectionPresence of Particulate Matter
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Eugia US LLC or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts